Dr. Lund is a Blood and Marrow Transplant Physician at the University of Minnesota Medical Center, Professor and Fellowship Program Director for the Division of Pediatric Blood and Marrow Transplantation & Cellular Therapy, Faculty in the Department of Pediatrics and the Masters Program in Stem Cell Biology and a BMT Specialist for the Pediatric Blood and Marrow Transplant (BMT) Center. Dr. Lund is interested in the use of hematopoietic stem cell transplantation (HSCT) primarily for patients with inherited metabolic disorders, like Adrenoleukodystrophy (ALD), Hurler syndrome (MPS-1H), Hunter syndrome, Metachromatic Leukodystrophy, and others. He studies the onset of disease, biomarkers of disease, mechanism of disease, and how HSCT improves the disease process. His work both in his research laboratory and with his patients has created many new approaches to treatment, which will ultimately make HSCT safer and more effective.
"Yes, we're saving lives. But that's not enough. I want to improve the quality of life for these kids, and that's where I'm focusing my energy."

Dr. Lund is an international expert on the use of cell and gene therapy for patients with inherited metabolic disorders and lysosomal storage disorders and has been named Minneapolis-St. Paul Top Doctor by Minneapolis-St. Paul Magazine.